Company / Depreciation & Amortization
Neogen Depreciation & Amortization History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$119.5M
FY2024
5-year range
$23.7M / $119.5M
FY2020-FY2024
Trend
+2.4%
vs FY2023
Sector context
#60 of 135
Health Care
What the data says
At $119M, Neogen's depreciation & amortization ranks #76 of 135 in the Health Care sector. Depreciation & Amortization has increased for 8 consecutive years, from $15M in FY2016 to $119M in FY2024.
Based on SEC 10-K filings.
$119M in FY2024 with a 5-year CAGR of +45.4%.
Increased from $88M to $119M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +71.5%
- 5-Year CAGR
- +45.4%
- 10-Year CAGR
- -
Sector benchmark
#76 of 135 in Health CareTop 56% of 135This company $119.5M Sector average $334.5M
▼
-64.3% below sector average
Key checks
Key Insights
- Neogen's depreciation & amortization has grown for 8 consecutive years.
- 5-year CAGR of +45.4%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 2.4% year-over-year.
- Ranks #60 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $119.5M | +2.4% |
| FY2023 | $116.7M | +32.1% |
| FY2022 | $88.4M | +273.0% |
| FY2021 | $23.7M | +12.6% |
| FY2020 | $21.0M | +14.4% |
| FY2019 | $18.4M | +4.4% |
| FY2018 | $17.6M | +3.3% |
| FY2017 | $17.1M | +16.1% |
| FY2016 | $14.7M | +20.6% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026